© 2021 MJH Life Sciences and Contagion Live. All rights reserved.
© 2021 MJH Life Sciences™ and Contagion Live. All rights reserved.
July 18, 2021
Investigators surveyed men who have sex with men (MSM) about long-acting injectable pre-exposure prophylaxis (PrEP) including attitudes towards potentially taking it and barriers to usage.
The pandemic's effect on in-person care prioritization may have indirectly influenced the rate of screening opportunities in at-risk persons.
New findings from CUSTOMIZE suggest the once-monthly injection therapy was feasibly implemented and generally favored to once-daily tablets.
Perspective gained from persons treated a real-world clinic may help better inform strategies to treat an HIV population that often struggles with viral suppression and consistent care.
A new study from IAS 2021 suggests persons with HIV hospitalized for COVID-19 do not face worse mortality nor major cardiovascular event risk.
July 01, 2021
The therapy, developed by Lupin Pharmaceuticals, now includes the treatment of trichomoniasis in adults patients and their partners.
June 24, 2021
More treatment options and modalities are now available for patients.
April 27, 2021
CDC report highlights disparities among “racial, ethnic, gender, and sexual” minorities.
April 20, 2021
The prevalence of this disease in this patient population is much higher than in the general public.
March 29, 2021
A new cohort assessment evidences a disparity in weight-related outcomes with the ART regimens at 18 months.